Compare SIBN & GCMG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | SIBN | GCMG |
|---|---|---|
| Founded | 2008 | 1971 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Finance/Investors Services |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 671.7M | 731.1M |
| IPO Year | 2018 | N/A |
| Metric | SIBN | GCMG |
|---|---|---|
| Price | $13.83 | $10.42 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 8 | 3 |
| Target Price | ★ $24.13 | $15.67 |
| AVG Volume (30 Days) | 512.4K | ★ 651.8K |
| Earning Date | 05-14-2026 | 01-01-0001 |
| Dividend Yield | N/A | ★ 4.61% |
| EPS Growth | ★ 41.33 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $67,301,000.00 | N/A |
| Revenue This Year | $16.89 | $7.28 |
| Revenue Next Year | $14.95 | $11.70 |
| P/E Ratio | ★ N/A | $28.21 |
| Revenue Growth | ★ 21.53 | N/A |
| 52 Week Low | $12.50 | $9.86 |
| 52 Week High | $21.89 | $13.55 |
| Indicator | SIBN | GCMG |
|---|---|---|
| Relative Strength Index (RSI) | 37.16 | 36.74 |
| Support Level | N/A | $10.35 |
| Resistance Level | $17.05 | $11.99 |
| Average True Range (ATR) | 0.75 | 0.40 |
| MACD | -0.09 | -0.10 |
| Stochastic Oscillator | 21.39 | 1.20 |
SI-BONE Inc is a medical device company, that develops and commercializes a proprietary minimally invasive surgical implant system in the United States and Internationally. Its products include a series of patented titanium implants and the instruments used to implant them, as well as implantable bone products such as iFuse-3D, iFuse-TORQ and iFuse Bedrock Granite which have applications across sacroiliac joint dysfunction and fusion, adult spinal deformity and degeneration, and pelvic trauma.
GCM Grosvenor Inc is a world-wide alternative asset management firm. It invests on behalf of clients who seek allocations to alternative investments, such as private equity, infrastructure, real estate, credit, ESG and absolute return strategies. Company invest maximum in Private Equity. The company's offerings include multi-manager portfolios as well as portfolios of direct investments and co-investments.